Back to results
CompletedPhase 1

Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab

NCT02649686

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

BCCA - Vancouver Cancer Centre

Vancouver, British Columbia, Canada

+2 additional locations

View on ClinicalTrials.gov
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab — TrialFind